Beijing promises to fight graft in healthcare sector

Want China Times, Xinhua 2013-08-11

GSK China's office in Beijing. (Photo/CFP)

Chinese health authorities will continue working with judicial agencies to fight bribery and graft in the healthcare sector, a spokesman said Friday.

The National Health and Family Planning Commission will step up its efforts to curb commercial bribery in the pharmaceutical industry and health service sector, commission spokesman Deng Haihua said at a press conference.

Parties that give and receive bribes will be investigated and punished, Deng said.

The commission also plans to blacklist pharmaceutical companies and individuals involved in bribery, he said.

British pharmaceutical giant GlaxoSmithKline (GSK) has been under investigation for suspected bribery and tax-related offenses by Chinese authorities since early July. Other salespeople and doctors are also being investigated for their alleged involvement.

Deng said health authorities are also working to stop corruption at its source by reforming public hospitals.

Authorities are trying to stop public hospitals and their doctors from profiting by overprescribing medicines by raising salaries so that medical workers can have decent and sustainable legal incomes, he said.

Efforts will be made to build an open and transparent public bidding platform for medicine and medical equipment, he said.

Related Articles:

Bribery 'routine' for foreign pharmaceutical firms in China - New
Foreign pharmas tread warily following GSK scandal in China

Police reveal details of GSK China's alleged violations

Beijing expands GSK bribery probe to other multinationals


"THE BRIDGE OF SWORDS"– Sep  29, 2012 (Kryon Channelling by Lee Carroll) - (Text version)

“… I'm in Canada and I know it, but I will tell those listening and reading in the American audience the following: Get ready! Because there are some institutions that are yet to fall, ones that don't have integrity and that could never be helped with a bail out. Again, we tell you the biggest one is big pharma, and we told you that before. It's inevitable. If not now, then in a decade. It's inevitable and they will fight to stay alive and they will not be crossing the bridge. For on the other side of the bridge is a new way, not just for medicine but for care. Paradigms that have not yet been thought of, which don't represent any system that currently exists, will be created and developed by young minds who have concepts that the seniors don't know about. Things that don't have integrity today will fall over tomorrow. Just get ready. It's all part of what's on the other side of the bridge. And the old energy won't like it, and they will object. …”